- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT03099811
Financial Incentives to Reduce Pediatric Tobacco Smoke Exposures
19 de noviembre de 2018 actualizado por: Johns Hopkins University
Contingency Management for Controlling Secondhand Smoke Exposures Among Asthmatic Children
Secondhand smoke exposure (SHSe) is one of the most common and potentially modifiable environmental triggers for asthma.
Financial incentivization may serve as an effective modality to reduce SHSe among pediatric asthmatics with potential down-stream benefits on improved asthma control and subsequent reduced healthcare utilization.
This study plans on testing the feasibility and effectiveness of financial incentives to decrease SHSe, derived from primary caregivers and a member of their social network, of children with persistent asthma.
Descripción general del estudio
Estado
Terminado
Condiciones
Intervención / Tratamiento
Descripción detallada
The impact of continued cigarette usage is profoundly felt not only upon the primary smoker, but also among children where SHSe is linked with asthma exacerbations.
Children with caregivers who are active smokers are more likely to utilize acute healthcare resources and miss more days of school due to asthma symptoms.
Issues of pediatric smoke exposure are notably higher among low-income populations.
This particular group has a greater amount of financial strain that increases their desire to cease smoking but is among the least successful at accomplishing this task.
Aggressive marketing campaigns by cigarette companies have specifically targeted the urban poor but similar techniques by public health officials, though on a much diminished scale, have yet to completely counter the hold that this addictive product has on members of lower socioeconomic status.
One approach that has demonstrated efficacy in reducing smoking in resistant populations emphasizes financial incentives.
Incentives may provide a substitute for the gratification derived from nicotine if they are properly structured.
This proposal applies a contingency management schema among caregivers of pediatric asthmatics and a member of their caregiver's social network - both of whom are likely major contributors to the child's total secondhand smoke exposure.
A pilot two-arm randomized-control trial will be employed over a 6-month time interval.The study population will consist of the primary caregiver and a selected member of their social network, both of who are known active smokers, and contemplating smoking cessation; both individuals spend time (either indoors or outdoors) with the asthmatic child.
We will recruit 50 caregiver-child-social network triads among a population of children diagnosed with uncontrolled, persistent asthma and routinely exposed to high levels of SHSe.
Caregivers and members of their social network who are both active smokers will be randomized to receive standard smoking cessation strategies (n=25 triads) with or without financial incentives (n=25 triads).
SHSe will be measured directly using salivary cotinine levels from children and home air nicotine levels.
Caregiver and social network member smoking behaviors will be measured by nicotine biomarkers; both test results will be the basis for incentive payments.
Asthma control will be evaluated using validated questionnaires and review of the participant's electronic health record.
Tipo de estudio
Intervencionista
Inscripción (Actual)
147
Fase
- No aplica
Contactos y Ubicaciones
Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.
Ubicaciones de estudio
-
-
Maryland
-
Baltimore, Maryland, Estados Unidos, 21287
- Johns Hopkins Hospital
-
-
Criterios de participación
Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.
Criterio de elegibilidad
Edades elegibles para estudiar
2 años a 12 años (Niño)
Acepta Voluntarios Saludables
Sí
Géneros elegibles para el estudio
Todos
Descripción
Inclusion Criteria:
- Primary caregiver aged greater than 18 years who is an active smoker.
- Child aged 2-12 years of age who meets clinical criteria for persistent asthma and has nicotine biomarker levels consistent with secondhand smoke exposure
- Designated social network member who is an active smoker
- Residence in Baltimore City
Exclusion Criteria:
- Child has current diagnosis of another major pulmonary disease or other significant medical co-morbidity
- Use of electronic cigarettes (e-cigarettes) by the adult-enrolled participants
Plan de estudios
Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Investigación de servicios de salud
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
---|---|
Experimental: Intervention: Financial incentives + Smoking cessation program
Caregiver and a social network member will receive financial incentives, in additional to enrollment in a state-sponsored smoking cessation program, based on nicotine biomarker measurements.
|
The caregiver and designated social network member can each receive monthly financial incentives over the 6 month time interval.
Additional monthly incentives will be received at 3- and 6-months if the participant's previous two monthly biomarker levels were below the lower-limit cutoff.
Otros nombres:
Participants who wish to quit smoking will be referred upon study recruitment to the smoking cessation program that is provided at no-cost by the Maryland Department of Health and Mental Hygiene (DMMH).
The DMMH provides standard counseling and nicotine replacement pharmacotherapies for clients and is offered online or at six health centers throughout Baltimore City.
Otros nombres:
|
Otro: Intervention: Smoking cessation program
Caregiver and a social network member will be enrolled in a state-sponsored smoking cessation program.
|
Participants who wish to quit smoking will be referred upon study recruitment to the smoking cessation program that is provided at no-cost by the Maryland Department of Health and Mental Hygiene (DMMH).
The DMMH provides standard counseling and nicotine replacement pharmacotherapies for clients and is offered online or at six health centers throughout Baltimore City.
Otros nombres:
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
---|---|---|
Pediatric secondhand smoke exposures
Periodo de tiempo: 6 months
|
Monthly measurement of pediatric secondhand smoke exposures.
Secondhand smoke exposures will be measured using salivary cotinine levels.
|
6 months
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
---|---|---|
Nicotine biomarkers
Periodo de tiempo: 6 months
|
Monthly measurements of nicotine biomarkers to objectively assess tobacco usage.
This will serve as the trigger for monthly financial incentives for those allocated to the intervention group.
|
6 months
|
Air nicotine
Periodo de tiempo: 6 months
|
Home air nicotine levels will be measured to assess if tobacco-derived indoor air pollutant levels will decline with the intervention.
Air nicotine levels will be acquired through passive air samplers and measured using gas chromatography.
|
6 months
|
Colaboradores e Investigadores
Aquí es donde encontrará personas y organizaciones involucradas en este estudio.
Patrocinador
Investigadores
- Investigador principal: Mandeep S Jassal, MD, Johns Hopkins University
Publicaciones y enlaces útiles
La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.
Fechas de registro del estudio
Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.
Fechas importantes del estudio
Inicio del estudio (Actual)
1 de junio de 2017
Finalización primaria (Actual)
1 de noviembre de 2018
Finalización del estudio (Actual)
1 de noviembre de 2018
Fechas de registro del estudio
Enviado por primera vez
17 de marzo de 2017
Primero enviado que cumplió con los criterios de control de calidad
28 de marzo de 2017
Publicado por primera vez (Actual)
4 de abril de 2017
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
20 de noviembre de 2018
Última actualización enviada que cumplió con los criterios de control de calidad
19 de noviembre de 2018
Última verificación
1 de noviembre de 2018
Más información
Términos relacionados con este estudio
Otros números de identificación del estudio
- IRB00064875
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
NO
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
No
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
No
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .
Ensayos clínicos sobre Incentive plan
-
University Hospital, LilleMinistry of Health, FranceDesconocido
-
University of California, San FranciscoWashington University School of Medicine; University of Washington; Pacific Pediatric... y otros colaboradoresReclutamientoMeduloblastoma | Meduloblastoma Infantil | Meduloblastoma RecurrenteEstados Unidos
-
Instituto de Investigación Hospital Universitario...Hospital Universitario La Paz; Fundacion para la Investigacion Biomedica del...TerminadoIdeación suicida | Suicidio, Intento | SuicidioEspaña
-
University of CopenhagenUniversity of Parma; Fundació Eurecat; ONMI; Simple Feast; AlimentómicaTerminadoObesidad | Exceso de peso | Síndrome metabólicoDinamarca
-
Wake Forest University Health SciencesNational Institute on Aging (NIA); Health Resources and Services Administration...ReclutamientoVIH | EnvejecimientoEstados Unidos
-
Assistance Publique - Hôpitaux de ParisTerminado
-
Weill Medical College of Cornell UniversityTerminadoResidentes de Pediatría Rotatorios en Oncología PediátricaEstados Unidos
-
University Hospitals Cleveland Medical CenterAmerican Academy of Pediatrics; Mt. Sinai Health Care FoundationTerminado
-
University of WashingtonPatient-Centered Outcomes Research Institute; Icahn School of Medicine at Mount... y otros colaboradoresTerminadoLesión cerebral traumáticaEstados Unidos